Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Cadent Therapeutics

Cadent Therapeutics was a Cambridge, Massachusetts-based precision neuroscience company developing drugs for the treatment of psychiatric diseases The company was acquired by Novartis in December 2020.

Overview Structured Data Issues Contributors Activity

Is a

Company

Organization

Company attributes

Industry

Location

Cambridge, Massachusetts

B2X

B2B

Pitchbook URL

pitchbook.com/profiles.../43122-52

Number of Employees (Ranges)

201 – 5000

Investors

‌

Cowen Healthcare Investments

Atlas Venture

Access Industries

QiMing Venture Partners

‌

Clal Biotechnology Industries

Founded Date

2013

Total Funding Amount (USD)

80,000,000

Latest Funding Round Date

November 15, 2018

Competitors

Gamida Cell

Acquisition Transaction

‌

Acquisition of Cadent Therapeutics by Novartis

Latest Funding Type

Series B Round

Patents Assigned (Count)

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Cadent Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API